Aurorium
Aurorium is a privately-held Indianapolis-based specialty ingredients manufacturer operating four cGMP-certified sites in North America, producing pharmaceutical excipients under its Haelium™ brand and industrial specialty chemicals for personal care, mobility, infrastructure, and paper & packaging customers worldwide.
- Company typePrivate
- Founded1857
- HeadquartersIndianapolis, United States
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Aurorium does
Aurorium is a privately-held specialty ingredients and performance materials manufacturer organized as Aurorium Holdings LLC and headquartered in Indianapolis, Indiana. The company produces high-purity pharmaceutical excipients, buffers, reagents, and solvents — marketed under the Haelium™ brand — alongside industrial specialty chemicals for personal & home care, mobility, infrastructure, and paper & packaging end-markets. Its core differentiator is vertical integration: Aurorium operates four cGMP-certified manufacturing sites in North America and is the only vertically-integrated manufacturer of NF/USP-grade NaOH solutions on the continent, producing NaOH pellets, high-purity water, and Water For Injection on-site at its Midlothian, Texas facility. Additional branded product lines include Castorlatum™ (plant-based emollient), Xibond™ (mobility additives), Bersize™ (paper sizing), and Ultrium™ (aluminum can production). Aurorium serves pharmaceutical manufacturers — particularly in peptide/oligonucleotide (TIDES) synthesis, biologics, and vaccines — as well as industrial customers across personal care, automotive, construction, and packaging industries. The company maintains European representative operations in the UK, Austria, and the Netherlands.
Aurorium operates a B2B direct sales model with quote-based pricing to enterprise customers and is supported by technical content marketing and industry trade presence rather than self-service or channel distribution. Revenue mechanics are based on recurring and project-based specialty chemical product sales, with the pharmaceutical ingredients segment (Haelium™) positioned as the primary growth driver and the industrial segments providing diversification. The company is a Responsible Care® signatory and prioritizes regulatory compliance and supply-chain reliability as core value propositions, particularly for pharmaceutical customers requiring long qualification cycles and consistent pharmacopeia-grade quality. Leadership transitioned in December 2024 with the appointment of Faye Freeman as CEO.
Aurorium firmographics
Firmographics- Name
- Aurorium
- Legal name
- Aurorium Holdings LLC
- Website
- https://aurorium.com
- Company type
- Private
- Founded year
- 1857
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Aurorium is a privately-held Indianapolis-based specialty ingredients manufacturer operating four cGMP-certified sites in North America, producing pharmaceutical excipients under its Haelium™ brand and industrial specialty chemicals for personal care, mobility, infrastructure, and paper & packaging customers worldwide.
- Ownership category
- akta.pro rank
Aurorium industry classification
Industry- Product category
- Specialty Chemicals
- NAICS
- Chemical Manufacturing (325), Other Chemical Product and Preparation Manufacturing (3259), Other Basic Inorganic Chemical Manufacturing (325180), Metal Coating, Engraving (except Jewelry and Silverware), and Allied Services to Manufacturers (332812)
- SIC
- Miscellaneous Chemical Products (2890), Chemicals & Allied Products (2800), Industrial Inorganic Chemicals (2810), Industrial Organic Chemicals (2860)
- akta.pro primary industry
- Coating & Adhesive Raw Materials (Resins, Additives, Solvents) (IMAEAGAK)
- akta.pro secondary industries
- Personal Care & Cosmetic Ingredients (IMAEABAJ), Metal Packaging Coatings & Linings (BPA-NI, Epoxy, Internal Coatings) (IMALADAK), Packaging & Can Coatings (IMAEAGAF)
Keywords
Where Aurorium is headquartered
LocationHeadquarters
- HQ city
- Indianapolis
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Aurorium business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Ingredients & Excipients: Sale of specialty pharmaceutical ingredients including high-purity buffers, reagents, solvents, NaOH solutions, and other excipients to pharmaceutical manufacturers. Revenue generated through product sales with recurring demand from drug manufacturing customers.
- Specialty Performance Materials: Sale of performance-enhancing specialty materials for personal & home care, mobility, infrastructure, and paper & packaging industries. Products include emollients, additives, and chemical solutions tailored to specific industrial applications.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Aurorium product offering
Product offeringCore offering
Aurorium manufactures and sells specialty ingredients and performance-enhancing materials to industrial customers across healthcare, personal & home care, mobility, infrastructure, and paper & packaging. Its Haelium™ brand delivers high-purity pharmaceutical buffers, reagents, solvents, NaOH solutions, piperidine, extended-release coatings, and immunostimulants, while complementary brands include Castorlatum™ emollients, Xibond™ additives, Bersize™ ASA technology, and Ultrium™ aluminum can solutions.
Differentiator
Problem solved
Functional benefit
Brands
- Haelium™: Pharmaceutical Solutions brand encompassing high-purity buffers, reagents, solvents, extended-release coatings, and immunostimulants for therapeutic areas including peptide and oligonucleotide production, large molecule biologics, vaccines, and oral solid dosage form.
- Xibond™
- Castorlatum™
- Bersize™
- Ultrium™
Products and services
- Haelium™ Pharmaceutical Solutions Comprehensive pharmaceutical ingredient brand encompassing high-purity buffers, reagents, solvents, extended-release coatings, and immunostimulants for therapeutic areas including peptide and oligonucleotide production, large molecule biologics, vaccines, and oral solid dosage forms. Built on four cGMP manufacturing sites in North America.
- Haelium™ Sodium Hydroxide Liquid (NaOH Solutions) Ready-to-use liquid NaOH solutions meeting U.S. and European Pharmacopeia (USP and EP) requirements, produced via vertically integrated manufacturing to eliminate additional preparation and minimize dust exposure risks.
- Haelium™ Piperidine High-purity reagent for manufacturing peptide-based therapeutics.
- Castorlatum™ Emollient Plant-based emollient serving as a sustainable alternative to petroleum jelly in personal care formulations such as skin care, lip care, and cosmetics.
- Xibond™ Additives Performance additives providing dimensional stability in demanding mobility environments such as automotive applications.
- Bersize™ ASA Technology Alkenyl Succinic Anhydride (ASA) technology driving efficiency in paper sizing applications for paper and packaging manufacturers.
- Ultrium™ 8900 Specialty solution unlocking efficiency and sustainability in aluminum can production.
Quantifiable outcome
- Reduced supply chain risk through vertical integration - produces NaOH pellets and solutions in-house rather than relying on third-party suppliers
- +2 more outcomes
Companies that use Aurorium
Customer profileSegments5 records
Ideal customer profiles5 records
Aurorium technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Aurorium partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights4 records
Aurorium competitors and assessment
Company assessmentDirect peers
- Innospec: Specialty chemicals company supplying performance additives, personal care actives, and fuel/oilfield chemicals — comparable mid-cap footprint to Aurorium, particularly in performance additives and personal care segments.
- Ashland: Specialty chemical company serving pharmaceuticals, personal care, and industrial markets with excipients, additives, and performance materials — comparable mid-scale footprint and end-market mix to Aurorium.
- Avantor: Avantor distributes and manufactures specialty chemicals and high-purity ingredients for pharmaceutical and life-science customers, directly overlapping Aurorium's Haelium™ excipients and NaOH/solvent portfolio.
- Croda International: Global specialty ingredients company focused on personal care, life sciences, and performance chemicals — directly comparable to Aurorium's Castorlatum™ emollient and personal/home care portfolio.
- EMD Millipore (MilliporeSigma): Life-science business of Merck KGaA supplying high-purity buffers, reagents, and solvents to pharma and biopharma — directly competes with Aurorium's Haelium™ pharmaceutical solutions in TIDES and biologics manufacturing.
- Lubrizol: Specialty chemicals producer with personal care ingredients, performance additives, and coatings — directly comparable to Aurorium's Castorlatum™, Xibond™, and Bersize™ product lines.
Others
- Evonik Industries: Large German specialty chemicals producer with extensive pharma excipients, personal care ingredients, and high-purity intermediates — overlaps with Aurorium across multiple verticals as a broad incumbent.
Broad incumbents
- Thermo Fisher Scientific (Patheon/CDMO chemicals): Through its chemicals and CDMO segments, Thermo Fisher supplies high-purity excipients and pharmaceutical ingredients to global drug manufacturers — overlapping with Aurorium's Haelium™ portfolio at much greater scale.
- BASF: World's largest chemical company with broad portfolios in pharma excipients, personal care ingredients, coatings, and packaging chemicals — competes with Aurorium across nearly every end-market at massive scale.
- Solvay: Belgian specialty chemicals major supplying soda ash/NaOH derivatives, high-purity reagents, and performance materials — overlapping with Aurorium's inorganic and pharmaceutical ingredient capabilities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Aurorium social profiles
Digital presenceAurorium financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aurorium leadership team
Management profileNumber of profiles
Profiles3 records
Aurorium funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aurorium M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aurorium
What does Aurorium do?
Aurorium manufactures and sells specialty ingredients and performance-enhancing materials to industrial customers across healthcare, personal & home care, mobility, infrastructure, and paper & packaging. Its Haelium™ brand delivers high-purity pharmaceutical buffers, reagents, solvents, NaOH solutions, piperidine, extended-release coatings, and immunostimulants, while complementary brands include Castorlatum™ emollients, Xibond™ additives, Bersize™ ASA technology, and Ultrium™ aluminum can solutions.
Is Aurorium a public or private company?
Aurorium is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Aurorium founded?
Aurorium was founded in 1857. It employs 1,001 to 5,000 people.
Where is Aurorium based?
Aurorium is headquartered in Indianapolis, United States, in the North America region.
How does Aurorium make money?
Two revenue lines are on record. Pharmaceutical Ingredients & Excipients are the primary driver. The others are specialty Performance Materials.
Who are Aurorium's main competitors?
Direct peers on record are Innospec, Ashland, Avantor, Croda International, EMD Millipore (MilliporeSigma) and Lubrizol. Evonik Industries is listed as an others. Broad incumbents are Thermo Fisher Scientific (Patheon/CDMO chemicals), BASF and Solvay.
Does Aurorium have an API?
No public API is recorded for Aurorium.
What industry is Aurorium in?
Aurorium's product category is Specialty Chemicals. Its primary akta.pro industry code is IMAEAGAK, Coating & Adhesive Raw Materials (Resins, Additives, Solvents), with a secondary code of IMAEABAJ, Personal Care & Cosmetic Ingredients. Its NAICS code is 325 and its SIC code is 2890.